Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine for spasticity in patients with diffuse axonal injury
IRCT20190810044500N27Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tizanidine in Muscle spasm and Diffuse axonal injury (DAI), sponsored by Shahid Sadoughi University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
tizanidine
03
Conditions
Muscle spasmDiffuse axonal injury (DAI)
Beyond the preview
Go deeper on IRCT20190810044500N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N27.